Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05277272 · ClinicalTrials.gov registry record
INTO-HLH: A Disease Registry for Patients With Hemophagocytic Lymphohistiocytosis (HLH)
A clinical trial of Hemophagocytic Lymphohistiocytoses, sponsored by Children's Hospital Medical Center, Cincinnati.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT05277272: Recruiting study of Hemophagocytic Lymphohistiocytoses, sponsored by Children's Hospital Medical Center, Cincinnati.
NCT05277272 is a study of Hemophagocytic Lymphohistiocytoses that is actively recruiting participants, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 200 participants, below the 680-participant average among 3 other Hemophagocytic Lymphohistiocytoses trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05277272, a study of Hemophagocytic Lymphohistiocytoses, is actively recruiting participants, sponsored by Children's Hospital Medical Center, Cincinnati.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this observational study is to collect data on the natural history of disease of patients with Hemophagocytic Lymphohistiocytosis (HLH) including diagnosis, treatments, responses, and outcomes.
Primary Outcome
Date of initial presentation and the date of HLH diagnosis as defined by HLH diagnostic criteria (HLH-2004/MAS classification criteria)
Conditions Studied
Study Locations (1)
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2021-12-31 |
| Est. Completion | 2027-01 |
What NCT05277272 shows while recruiting
NCT05277272 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 680-participant average among 3 other Hemophagocytic Lymphohistiocytoses trials with a reported enrollment target (71% lower).
The record links to 1 condition, with Hemophagocytic Lymphohistiocytoses appearing as the primary indexed condition, and to 0 interventions.
NCT05277272 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT05277272 about?
NCT05277272 is a clinical study titled "INTO-HLH: A Disease Registry for Patients With Hemophagocytic Lymphohistiocytosis (HLH)". The purpose of this observational study is to collect data on the natural history of disease of patients with Hemophagocytic Lymphohistiocytosis (HLH) including diagnosis, treatments, responses, and outcomes.
What is the current status of trial NCT05277272?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2021-12-31. Estimated completion is 2027-01.
What conditions does trial NCT05277272 study?
This clinical trial studies the following conditions: Hemophagocytic Lymphohistiocytoses.
Who is sponsoring clinical trial NCT05277272?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05277272 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hemophagocytic Lymphohistiocytoses
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Describing Treatment Outcomes and Responses in Lymphoma-associated Hemophagocytic Lymphohistiocytosis
RECRUITING
-
Ruxolitinib With De-Intensified HLH-94 for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH)
RECRUITING · Phase 2
-
Haploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 Depletion
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI